Skip to main content
SpringerLink
Log in

When and How to Stop Cabergoline Treatment in Microprolactinomas

  • Chapter
A Case-Based Guide to Clinical Endocrinology

Part of the book series: Contemporary Endocrinology™ ((COE))

  • 1752 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 249.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gillam MP, Molitch ME, Lombardi G, Colao A. Advances in the treatment of prolactinomas. Endocr Rev 2006. Aug 27(5):485–534.

    Article  PubMed  CAS  Google Scholar 

  2. Comtois R, Robert F, Hardy J. Immunoradiometric assays may miss high prolactin levels. Ann Intern Med 1993;119:173.

    PubMed  CAS  Google Scholar 

  3. Webster J, Piscitelli G, Polli A, Ferrari CI, Ismail I, Scanlon MF. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group. N Engl J Med 1994;331:904–909.

    Article  PubMed  CAS  Google Scholar 

  4. Biller BM, Molitch ME, Vance ML, et al. Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline. J Clin Endocrinol Metab 1996;81:2338–2343.

    Article  PubMed  CAS  Google Scholar 

  5. Delgrange E, Maiter D, Donckier J. Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine. Eur J Endocrinol 1996;134:454–456.

    Article  PubMed  CAS  Google Scholar 

  6. Colao A, Di Sarno A, Sarnacchiaro F, et al. Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment. J Clin Endocrinol Metab 1997;82:876–883.

    Article  PubMed  CAS  Google Scholar 

  7. Di Sarno A, Landi ML, Cappabianca P, et al. Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy. J Clin Endocrinol Metab 2001;86:5256–5261.

    Article  PubMed  Google Scholar 

  8. Colao A, Di Sarno A, Cappabianca P, Di Somma C, Pivonello R, Lombardi G. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. N Engl J Med 2003;349:2023–2033.

    Article  PubMed  CAS  Google Scholar 

  9. Jho HD. Endoscopic pituitary surgery. Pituitary 1999;2:139–154.

    Article  PubMed  CAS  Google Scholar 

  10. Cappabianca P, Cavallo LM, de Divitiis E. Endoscopic endonasal transsphenoidal surgery. Neurosurgery 2004;55:933–940; discussion 940–941.

    Article  PubMed  Google Scholar 

  11. Molitch ME. Medical treatment of prolactinomas. Endocrinol Metab Clin North Am 1999;28:143–169, vii.

    Article  PubMed  CAS  Google Scholar 

  12. Johnston DG, Hall K, Kendall-Taylor P, Patrick D, Watson M, Cook DB. Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. Studies with high-definition computerized tomography. Lancet 1984;2:187–192.

    Article  PubMed  CAS  Google Scholar 

  13. Koppelman MC, Jaffe MJ, Rieth KG, Caruso RC, Loriaux DL. Hyperprolactinemia, amenorrhea, and galactorrhea. A retrospective assessment of twenty-five cases. Ann Intern Med 1984;100:115–121.

    PubMed  CAS  Google Scholar 

  14. March CM, Kletzky OA, Davajan V, et al. Longitudinal evaluation of patients with untreated prolactin-secreting pituitary adenomas. Am J Obstet Gynecol 1981;139:835–844.

    PubMed  CAS  Google Scholar 

  15. Schlechte J, Dolan K, Sherman B, Chapler F, Luciano A. The natural history of untreated hyperprolactinemia: a prospective analysis. J Clin Endocrinol Metab 1989;68:412–418.

    PubMed  CAS  Google Scholar 

  16. Sisam DA, Sheehan JP, Sheeler LR. The natural history of untreated microprolactinomas. Fertil Steril 1987;48:67–71.

    PubMed  CAS  Google Scholar 

  17. Von Werder K, Eversmann T, Fahlbusch R, Rjosk H-K. Development of hyperprolactinemia in patients with adenomas with and without prior operative treatment. Excerpta Med Int Congr Ser 1982;584:175–188.

    Google Scholar 

  18. Weiss MH, Teal J, Gott P, et al. Natural history of microprolactinomas: six-year follow-up. Neurosurgery 1983;12:180–183.

    PubMed  CAS  Google Scholar 

  19. Crosignani PG, Mattei AM, Severini V, Cavioni V, Maggioni P, Testa G. Long-term effects of time, medical treatment and pregnancy in 176 hyperprolactinemic women. Eur J Obstet Gynecol Reprod Biol 1992;44:175–180.

    Article  PubMed  CAS  Google Scholar 

  20. Jeffcoate WJ, Pound N, Sturrock ND, Lambourne J. Long-term follow-up of patients with hyperprolactinaemia. Clin Endocrinol (Oxf) 1996;45:299–303.

    Article  CAS  Google Scholar 

  21. Karunakaran S, Page RC, Wass JA. The effect of the menopause on prolactin levels in patients with hyperprolactinaemia. Clin Endocrinol (Oxf) 2001;54:295–300.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Professor of Endocrinology, Department of Molecular Clinical Endocrinology and Oncology, Federico II, University of Naples, Naples, Italy

    Annamaria Colao

Authors
  1. Annamaria Colao
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Mount Sinai School of Medicine, The Mount Sinai Hospital and the James J. Peters VA Medical Center, New York, NY

    Terry F. Davies

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press,Totowa, NJ

About this chapter

Cite this chapter

Colao, A. (2008). When and How to Stop Cabergoline Treatment in Microprolactinomas. In: Davies, T.F. (eds) A Case-Based Guide to Clinical Endocrinology. Contemporary Endocrinology™. Humana Press. https://doi.org/10.1007/978-1-60327-103-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-103-5_2

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-815-7

  • Online ISBN: 978-1-60327-103-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation